Symposium:
160. Vancomycin-Resistant Enterococcus
Saturday, October 5, 2013: 8:30 AM-10:00 AM
Room: The Moscone Center: 104 (Gateway Ballroom)

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • summarize results of recent enterococcal genomic analyses and their implications
  • discuss daptomycin-resistance in enterococci and implications
  • describe the effect of antibiotics on vancomycin-resistant enterococci colonization of the gastrointestinal tract

Target Audience: scientists, researchers, microbiologists, members-in-training, investigators, infectious diseases physicians, infectious diseases pediatricians, hospital epidemiologists, fellows, epidemiologists, clinicians, academicians

Tracks: Investigative ID, Epidemiology and Infection Control, Adult ID

Moderators:  Eric Pamer, MD, FIDSA, Memorial Sloan-Kettering Cancer Center and Cesar Arias, MD PhD, University of Texas Medical School At Houston

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-117-L01-P

Disclosures:

E. Pamer, None

C. Arias, Cubist Pharmaceuticals: Consultant and Speaker's Bureau, Consulting fee and Speaker honorarium
Pfizer, Inc: Consultant, Investigator, Scientific Advisor and Speaker's Bureau, Consulting fee, Grant recipient and Speaker honorarium
Theravance: Investigator, Research grant
Forest Pharmaceuticals: Investigator and Speaker's Bureau, Grant recipient and Speaker honorarium
UptoDate: Co-Author, Licensing agreement or royalty

B. Murray, Cubist: Investigator, Grant recipient
Theravance: Investigator and Scientific Advisor, Consulting fee and Grant recipient

C. Arias, Cubist Pharmaceuticals: Consultant and Speaker's Bureau, Consulting fee and Speaker honorarium
Pfizer, Inc: Consultant, Investigator, Scientific Advisor and Speaker's Bureau, Consulting fee, Grant recipient and Speaker honorarium
Theravance: Investigator, Research grant
Forest Pharmaceuticals: Investigator and Speaker's Bureau, Grant recipient and Speaker honorarium
UptoDate: Co-Author, Licensing agreement or royalty

C. Ubeda, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.